Sumanas W. Jordan

Sumanas W. Jordan

Auto-generated profile, based on publicly available information

Sumanas W. Jordan

Division of Plastic & Reconstructive Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2020 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Closed access
LMLauren M. Mioton
Lauren M. Mioton
GDGregory A. Dumanian
Gregory A. Dumanian
NSNikita Ba Shah
Nikita Ba Shah
CQCecil S. Qiu
Cecil S. Qiu
WEWilliam J. Ertl
William J. Ertl
SJSumanas W. Jordan
Sumanas W. Jordan
Background: Targeted muscle reinnervation is an emerging surgical technique to treat neuroma pain whereby sensory and mixed motor nerves are transferred to nearby redundant motor nerve branches. In a recent randomized controlled trial, targeted muscle reinnervation was recently shown to reduce postamputation pain relative to conventional neuroma excision and muscle burying. Questions/purposes: (1) Does targeted muscle reinnervation improve residual limb pain and phantom limb pain in the period before surgery to 1 year after surgery? (2) Does targeted muscle reinnervation improve Patient-reported Outcome Measurement System (PROMIS) pain intensity and pain interference scores at 1 year after surgery? (3) After 1 year, does targeted muscle reinnervation improve functional outcome scores (Orthotics Prosthetics User Survey [OPUS] with Rasch conversion and Neuro-Quality of Life [Neuro-QOL])? Methods: Data on patients who were ineligible for randomization or declined to be randomized and underwent targeted muscle reinnervation for pain were gathered for the present analysis. Data were collected prospectively from 2013 to 2017. Forty-three patients were enrolled in the study, 10 of whom lacked 1-year follow-up, leaving 33 patients for analysis. The primary outcomes measured were the difference in residual limb and phantom limb pain before and 1 year after surgery, assessed by an 11-point numerical rating scale (NRS). Secondary outcomes were change in PROMIS pain measures and change in limb function, assessed by the OPUS Rasch for upper limbs and Neuro-QOL for lower limbs before and 1 year after surgery. Results: By 1 year after targeted muscle reinnervation, NRS scores for residual limb pain from 6.4 ± 2.6 to 3.6 ± 2.2 (mean difference -2.7 [95% CI -4.2 to -1.3]; p < 0.001) and phantom limb pain decreased from 6.0 ± 3.1 to 3.6 ± 2.9 (mean difference -2.4 [95% CI -3.8 to -0.9]; p < 0.001). PROMIS pain intensity and pain interference scores improved with respect to residual limb and phantom limb pain (residual limb pain intensity: 53.4 ± 9.7 to 44.4 ± 7.9, mean difference -9.0 [95% CI -14.0 to -4.0]; residual limb pain interference: 60.4 ± 9.3 to 51.7 ± 8.2, mean difference -8.7 [95% CI -13.1 to -4.4]; phantom limb pain intensity: 49.3 ± 10.4 to 43.2 ± 9.3, mean difference -6.1 [95% CI -11.3 to -0.9]; phantom limb pain interference: 57.7 ± 10.4 to 50.8 ± 9.8, mean difference -6.9 [95% CI -12.1 to -1.7]; p ≤ 0.012 for all comparisons). On functional assessment, OPUS Rasch scores improved from 53.7 ± 3.4 to 56.4 ± 3.7 (mean difference +2.7 [95% CI 2.3 to 3.2]; p < 0.001) and Neuro-QOL scores improved from 32.9 ± 1.5 to 35.2 ± 1.6 (mean difference +2.3 [95% CI 1.8 to 2.9]; p < 0.001). Conclusions: Targeted muscle reinnervation demonstrates improvement in residual limb and phantom limb pain parameters in major limb amputees. It should be considered as a first-line surgical treatment option for chronic amputation-related pain in patients with major limb amputations. Additional investigation into the effect on function and quality of life should be performed. Level of Evidence: Level IV, therapeutic study.

1 November 2022 in JAMA Pediatrics
Verified
Journal Article
Open access
PDF file
MAMona Ascha
Mona Ascha
DSDaniel C. Sasson
Daniel C. Sasson
RSRachita Sood
Rachita Sood
JCJeremy W. Cornelius
Jeremy W. Cornelius
JSJacob M. Schauer
Jacob M. Schauer
SJSumanas W. Jordan
Sumanas W. Jordan
Recent studies estimate that up to 9% of adolescents and young adults (AYA) identify as transgender or nonbinary (TGNB).1 Many TGNB youth designated female at birth (DFAB) experience chest dysphoria, defined as distress related to the development of breasts.2 Chest dysphoria can lead to negative physical and emotional consequences, such as lack of participation in exercise and sports, chest-binding practices that can be physically harmful when not performed safely, psychosocial distress, functional limitations, and suicidal ideation.2-4 A retrospective review by our group of 156 TGNB DFAB AYA aged 12 to 18 years found that chest dysphoria was associated with greater anxiety and depression independent of gender dysphoria, degree of appearance congruence, and social transition status.5 TGNB youth may perform chest binding to relieve gender dysphoria, improve social acceptance, and reduce misgendering.3 However, chest binding may cause skin irritation, musculoskeletal pain, and shortness of breath.6 Prior research has shown that most TGNB youth who perform chest binding desire definitive top surgery.3

1 July 2020 in Plastic and Reconstructive Surgery - Global Open
Verified
Journal Article
Open access
LMLauren M. Mioton
Lauren M. Mioton
GDGregory A. Dumanian
Gregory A. Dumanian
MFMegan E. Fracol
Megan E. Fracol
AAA. Vania Apkarian
A. Vania Apkarian
IVIan L. Valerio
Ian L. Valerio
SJSumanas W. Jordan
Sumanas W. Jordan
Background: More than 75% of major limb amputees experience chronic pain; however, data on severity and experience of pain are inconsistent. Without a benchmark using quantitative patient-reported outcomes, it is difficult to critically assess the efficacy of novel treatment strategies. Our primary objective is to report quantitative pain parameters for a large sample of amputees using the validated Patient-reported Outcomes Measurement System (PROMIS). Secondarily, we hypothesize that certain patient factors will be associated with worse pain. Methods: PROMIS and Numerical Rating Scales for residual limb pain (RLP) and phantom limb pain (PLP) were obtained from a cross-sectional survey of upper and lower extremity amputees recruited throughout North America via amputee clinics and websites. Demographics (gender, age, race, and education) and clinical information (cause, amputation level, and time since amputation) were collected. Regression modeling identified factors associated with worse pain scores (P < 0.05). Results: Seven hundred twenty-seven surveys were analyzed, in which 73.4% reported RLP and 70.4% reported PLP. Median residual PROMIS scores were 46.6 [interquartile range (IQR), 41–52] for RLP Intensity, 56.7 (IQR, 51–61) for RLP Behavior, and 55.9 (IQR, 41–63) for RLP Interference. Similar scores were calculated for PLP parameters: 46.8 (IQR, 41–54) for PLP Intensity, 56.2 (IQR, 50–61) for PLP Behavior, and 54.6 (IQR, 41–62) for PLP Interference. Female sex, lower education, trauma-related amputation, more proximal amputation, and closer to time of amputation increased odds of PLP. Female sex, lower education, and infection/ischemia-related amputation increased odds of RLP. Conclusion: This survey-based analysis provides quantitative benchmark data regarding RLP and PLP in amputees with more granularity than has previously been reported.

26 October 2021 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
NLNatalie Luehmann
Natalie Luehmann
MAMona Ascha
Mona Ascha
ECEmily Chwa
Emily Chwa
PHPaige Hackenberger
Paige Hackenberger
KTKareem Termanini
Kareem Termanini
SJSumanas W. Jordan
Sumanas W. Jordan

23 September 2020 in Microsurgery
Verified
Journal Article
Closed access
PDF file
JSJenna R. Stoehr
Jenna R. Stoehr
RSRachita Sood
Rachita Sood
SJSumanas W. Jordan
Sumanas W. Jordan
GDGregory A. Dumanian
Gregory A. Dumanian

11 October 2018 in Advances in Wound Care
Verified
Journal Article
Open access
JWJulie M. West
Julie M. West
SJSumanas W. Jordan
Sumanas W. Jordan
EMEhud Mendel
Ehud Mendel
SKSafdar N. Khan
Safdar N. Khan
RCRajiv Y. Chandawarkar
Rajiv Y. Chandawarkar
IVIan L. Valerio
Ian L. Valerio
Objective: Infection prevention in spinal surgeries involving implantation of hardware is of utmost priority. Furthermore, successful eradication of infection in hardware salvage is likewise critical in maintaining the long-term retention of the spinal hardware construct. Approach: We report a retrospective case series of three cases where the utilization of a VAC with instillation (VACi) in conjunction with surgical debridement aided in infection control and eradication for both preimplantation and hardware salvage spine patients. Results: Three patients were included. In case 1, VACi was utilized in conjunction with surgical debridement and IV antibiotics in the setting of acute preoperative infection to eradicate infection and enable necessary spinal hardware implementation. Cases 2 and 3 are representative of VACi for salvage of exposed spinal hardware in both the early and delayed infection presentation settings. In both cases, patients developed postoperative infections following spinal instrumentation VACi was utilized in conjunction with surgical debridement and IV antibiotics. Hardware removal was avoided in both cases. All three patients healed completely without residual evidence of infection. Innovation: VACi showed its effectiveness in timely infection eradication before spinal hardware instrumentation and with postoperative spine hardware salvage. Conclusion: This case series demonstrates that VACi can provide infection eradication both preoperatively in high-risk surgical sites, facilitating necessary hardware implementation and postoperatively in situations of hardware salvage.